Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8623927 | Trends in Anaesthesia and Critical Care | 2017 | 4 Pages |
Abstract
- Remifentanil PCA is arguably the second most effective analgesic method in labour after neuro-axial analgesia.
- Remifentanil PCA has not had long-term sequelae described so far. It is not hazardous to the environment or medical staff.
- The unique metabolism of remifentanil into inactive products without accumulation presents a benefit over other opioids.
- It is associated with the risk of respiratory suppression in the mother and neonate which implies strict safety standards.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Andrea Anna Melber, Alex Tiong Heng Sia,